The field of the invention is that of stents and the attachment of stents to grafts useful for insertion into a body passageway, and in particular stents and grafts for use in a vascular passageway.
Stent-grafts are used in body lumens and in particular, in vascular lumens. These grafts allow the use of the lumen in situations where the lumen may have a defect, such as a stenosis or an aneurysm. Stents perform functions that make them useful in combination with grafts. External stents are used to pull grafts open while avoiding the use of metallic materials on the inside of a graft, where the metals would be in contact with body fluids, such as blood. External stents thus avoid placement where they would be in contact with the body fluid. External stents, outside the graft, also avoid interference with the flow of the body fluid and are not an obstacle to passage of other medical devices though the inside of the graft. Internal stents are used to push the grafts open and to help seal the graft against the vessel wall. A stent, such as a zigzag stent, also may be used to anchor a graft in place, provided there are anchors or barbs on the stent for securing the stent, and hence the graft, in the desired location.
Previous grafts have included stents, but sometimes have defects that hinder their use. For example, FIG. 2 of U.S. Pat. No. 6,004,347 depicts a stent that may be difficult to manufacture because of the many resistance welds. A more serious difficulty is the method used to attach the stent to the graft. In order to properly secure the stent to the graft, according to the patent, eight penetrations or holes are needed for four successive stitches. Each stitch is positioned further away from a bend in the proximal end of the stent. This method spreads out the stress on the graft from the stent, but requires many penetrations per bend of the stent.
FIGS. 17-18 of U.S. Pat. No. 6,287,330 and FIGS. 19-21 of U.S. Pat. No. 6,221,102 depict stents used to secure a graft material. In these examples, the stent is separate from an attachment system that anchors the graft to the body lumen. Many stitches are required to secure the stent and the attachment system to the graft.
One aspect of the invention is an endoluminal prosthetic device, comprising a graft comprising a bio-compatible material forming at least one lumen, a first stent comprising a plurality of struts and apices between the struts, at least two of the apices in the first stent secured to the graft by stitches. The endoluminal prosthetic device also comprises a second stent comprising a plurality of struts and apices between the struts, at least two of the apices secured to the graft by stitches, wherein at least one stitch of the first stent and at least one stitch of the second stent are joined in a running suture.
Another aspect of the invention is a method of forming an endoluminal prosthetic device, the method comprising providing a graft, and joining a first stent to the graft, the first stent comprising a plurality of struts and apices between the struts, by at least a stitch on each apex. The method also comprises joining a second stent to the graft, the second stent comprising a plurality of struts and apices between the struts, by at least a stitch on each apex, and linking at least one stitch of the first stent and one stitch of the second stent with a running suture. There are many ways to practice the present invention, as shown in the following drawings and specification. The embodiments are not meant to limit the invention, but rather to describe and illustrate some of the ways that the present invention may be used.
a is an elevational view of a second embodiment;
b is a closer view of
An endoluminal prosthetic device in accordance with the present disclosure is presented in
Device 10 also includes at least one anchoring stent 12 and an internal stent 14. These stents may be in the form of zigzag stents, that is, a continuous chain of struts 15 and joints of apices 16. Zigzag stents known by the trademark Cook-® and stent-grafts for abdominal aortic aneurysm (AAA) repair, made by Cook Incorporated of Bloomington, Ind., are examples of commercial embodiments. Serpentine stents, having curved struts, may also be used.
The preferred embodiment includes an external stent 20. A stent is formed from linear portions or struts 15 and the apex or apices 16 at which the struts meet. In addition, anchoring or exposed stent 12 may include anchors 17, small barbs or hooks that will anchor the stent to the internal wall of a body lumen, such as a wall of an aorta. Anchoring stents are preferably secured to an inside of the graft with sutures. Resiliently compressible, self-expanding stents are preferred in order to seal with the body lumen. PCT Application WO 98/53761, hereby incorporated by reference in its entirety, discloses a number of details concerning stents, stent grafts, and a method for implanting stent grafts into the human body.
The suture may be made of any biocompatible fiber suitable for the application, including but not limited to, monofilament or braided multi-filament material made of polyester, nylon, polyaramid, polypropylene, and polyethylene. Green, braided polyester 4-0 suture material is preferred for attaching internal stents to grafts, while monofilament suture material is preferred for attaching anchoring stents to grafts. The polyester 4-0 suture material is nonabsorbable and has commercial size limits of 0.150 to 0.199 mm (metric size 1.5). Suture materials are commercially available from a number of companies, such as Genzyme Biosurgery, Fall River, Mass. The suture material may be attached to a hollow needle used to thread the suture through the graft, thus attaching the stent to the graft. In making the sutures at the joints described above, suturing may begin at any convenient point.
In the present context, suture means the thread or material that secures the stents to the graft. Suture may also refer to the configuration of this material in a loop, the material securing a portion of a stent to a graft. A suture is made by looping material through the graft and around the stent or an apex of a stent. A knot is then tied, intertwining the ends of the suture in such a way that they will not be easily separated. A suture may have more than one knot. In some cases, or in many cases, an apex of a stent may be secured to the graft by two loops of suture or thread through the graft and also through or around the apex of the stent, and then secured with one knot or more than one knot, in essence tying the ends of the suture. Knots may be locking knots, preferred for apices, or overthreaded knots, preferred along the length of the strut or for other applications. Knots in the stent-graft may include any other useful or desired knots and are not limited to these types.
If the ends of the knot are not cut, the thread or suture may be led by a needle or other mechanical device to the next point on the endoluminal prosthetic device where a suture is desired. The thread or material that joins the first suture to the next suture may be called a running suture, because the thread or suture “runs” between the sutures. A stitch is a single suture. In the present context, every suture is secured with a knot, and where there is a suture, there is at least one loop of thread or material securing a portion of a stent to a graft, and a knot securing the suture. Therefore, whenever a suture other than a running suture is indicated, there is also a knot; the suture and the knot are not shown separately in the drawings.
Sutures for stents are typically not single sutures or single stitches, but typically include two loops through the graft and around the stent or apex that is being joined. The sutures may then be affixed with one or more knots. When the thread penetrates the graft in a two-loop suture, it may be difficult for the needle or other device to penetrate the exact same threads of the graft or the exact same opening with every loop, although this is desired. In the present context, when two stitches share an opening, and there are actually two openings, the sutures are construed as sharing the same opening or penetration if the stitches are within 0 to about 5 threads (warp or weft threads) of each other. Zero is preferable. If a graft is made of a continuous material, such as a biomaterial or collagen, there are no discrete threads in the graft, and the sutures are construed as sharing the same opening or penetration if they are within one suture diameter of each other.
The details of the construction of the endoluminal prosthetic device of
The stents may be made from one or more of several materials. These materials include, but are not limited to, stainless steel, titanium, Nitinol, Elgiloy, and shape memory material. These stents are desirably in the form of a zigzag stent, a continuous chain of struts and intersections where the struts meet. As noted above, anchoring stent 12 may have one or more anchors 17, or small barbs, as depicted in greater detail in
The graft, as discussed above, should be suitable for placement inside a person, although these grafts are not limited to uses for humans and may also be used for animals. The graft 11, as depicted in
The embodiment described in
The top edge of graft 11 is preferably formed into a cuff 13 of double thickness in the top half-inch or top quarter-inch, to add strength to the graft where it is most needed. The stitches are preferably made on an outside periphery of the graft. Stitches may also be made on an inside periphery of the graft, but the outside is preferred because it is easier to work on the outside and to leave the “running” portion of the running sutures on the outside of the graft. In addition, it is preferable to leave the inside surfaces of the graft as free from interruptions as possible, in order to avoid thrombi and to encourage flow of body fluids to the greatest extent possible.
Another embodiment uses a different running suture, as depicted in
The stents are joined to the graft with stitches or sutures 55, depicted as lines in the figures, using holes or penetrations 54 in graft 51. In this embodiment, anchoring stent 52 is joined to the graft with only a single stitch 55 at the bottom apex 52c of each pair of struts 52a, 52b. Internal strut 53 is joined to graft 51 by stitches 53f at bottom and top apices 53c, 53e. The stitches for anchoring stent bottom apex 52c and internal stent top apex 53e are linked by a running suture 59. An additional running suture 57 also extends to one additional top apex 53e. That is, in this embodiment, the running sutures also join the stitches or sutures securing the second-nearest top apex 53e to graft 51. In addition, stitches for internal strut 53 are also linked by a running suture 58 between the stitches. In practice, this structure may be achieved by chain-suturing internal stent 53 to graft 51, and then adding anchoring stent 52 and chain-suturing anchoring stent 52 to the graft in the manner shown with running sutures 57, 59.
It is understood that every joint for a running suture requires at least one stitch, i.e. two openings or penetrations in the graft (whether existing or additional openings), at least a single loop of thread, and at least one knot securing the threads in the area of the penetrations. Adding these additional running sutures strengthens the endoluminal prosthetic device and better secures the stents to the graft. It is preferable to use more than one suture per hole or opening in the graft to achieve a running suture in this manner, rather than to have additional openings.
b is a magnified view of the embodiment of
Another embodiment is depicted in
Another embodiment is depicted in
An embodiment of the suturing pattern of
Device 80 also comprises at least one internal stent 85, anchored to upper portion 81 in the manner described for the embodiment of
Another embodiment is depicted in
The bifurcated prosthesis 120 has a generally inverted Y-shaped configuration. The prosthesis 120 includes a body 123, a shorter leg 160 and a longer leg 132. The bifurcated prosthesis 120 comprises a tubular graft material, such as polyester, with self-expanding stents 119 attached thereto. The self-expanding stents 119 cause the prosthesis 120 to expand following its release from the introducer 100. The prosthesis 120 also includes a self-expanding zigzag stent 121 that extends from its proximal end. The self-expanding zigzag stent 121 has distally extending barbs 151. When it is released from the introducer 100, the self-expanding zigzag stent 121 anchors the barbs 151, and thus the proximal end of the prosthesis 120, to the lumen of the patient.
The self-expanding tubular prosthesis 150 is similar to the bifurcated prosthesis 120, but has a unitary (i.e. non-bifurcated) lumen. The tubular prosthesis 150 also comprises a tubular graft material, such as polyester, having self-expanding stents attached thereto. The tubular prosthesis 150 is configured to connect to the shorter leg 160 of the bifurcated prosthesis 120.
The introducer 100 includes an external manipulation section 101, a distal attachment region 102 and a proximal attachment region 103. The distal attachment region 102 and the proximal attachment region 103 secure the distal and proximal ends of the prosthesis 120, respectively. During the medical procedure to deploy the prosthesis 120, the distal and proximal attachment regions 102 and 103 will travel through the lumen to a desired deployment site. The external manipulation section 101, which is acted upon by a user to manipulate the introducer, remains outside of the patient throughout the procedure.
The proximal attachment region 103 of the introducer 100 includes a cylindrical sleeve 110. The cylindrical sleeve 110 has a long tapered flexible extension 111 extending from its proximal end. The flexible extension 111 has an internal longitudinal aperture (not shown). This longitudinal aperture facilitates advancement of the tapered flexible extension 111 along an insertion wire (not shown). The longitudinal aperture also provides a channel for the introduction of medical reagents. For example, it may be desirable to supply a contrast agent to allow angiography to be performed during placement and deployment phases of the medical procedure.
A thin walled metal tube 115 is fastened to the extension 111. The thin walled metal tube 115 is flexible so that the introducer 100 can be advanced along a relatively tortuous vessel, such as a femoral artery, and so that the distal attachment region 102 can be longitudinally and rotationally manipulated. The thin walled metal tube 115 extends through the introducer 100 to the manipulation section 101, terminating at a connection means 116.
The connection means 116 is adapted to accept a syringe to facilitate the introduction of reagents into the thin walled metal tube 115. The thin walled metal tube 115 is in fluid communication with the apertures 112 of the flexible extension 111. Therefore, reagents introduced into connection means 116 will flow to and emanate from the apertures 112.
A plastic tube 141 is coaxial with and radially outside of the thin walled metal tube 115. The plastic tube 141 is “thick walled”—its wall is preferably several times thicker than that of the thin walled metal tube 115. A sheath 130 is coaxial with and radially outside of the plastic tube 141. The thick walled plastic tube 141 and the sheath 130 extend distally to the manipulation region 101.
During the placement phase of the medical procedure, the prosthesis 120 is retained in a compressed condition by the sheath 130. The sheath 130 extends distally to a gripping and haemostatic sealing means 135 of the external manipulation section 101. During assembly of the introducer 100, the sheath 130 is advanced over the cylindrical sleeve 110 of the proximal attachment region 103 while the prosthesis 120 is held in a compressed state by an external force. A distal attachment (retention) section 140 (inside sheath 130 and not visible in this view) is coupled to the thick walled plastic tube 141. The distal attachment section 140 retains a distal end 142 of the prosthesis 120 during the procedure. Likewise, the cylindrical sleeve 110 retains the self-expanding zigzag stent 121.
The distal end 142 of the prosthesis 120 is retained by the distal attachment section 140. The distal end 142 of the prosthesis 120 has a loop (not shown) through which a distal trigger wire (not shown) extends. The distal trigger wire extends through an aperture (not shown) in the distal attachment section 140 into an annular region between the thin walled tube 115 and the thick walled tube 141. The distal trigger wire extends through the annular space to the manipulation region 101. The distal trigger wire exits the annular space at a distal wire release mechanism 125.
The external manipulation section 101 includes a haemostatic sealing means 135. The haemostatic sealing means 135 includes a haemostatic seal (not shown) and a side tube 129. The haemostatic sealing means 135 also includes a clamping collar (not shown) that clamps the sheath 130 to the haemostatic seal, and a silicone seal ring (not shown) that forms a haemostatic seal around the thick walled plastic tube 141. The side tube 129 facilitates the introduction of medical reagents between the thick walled tube 141 and the sheath 130.
A proximal portion of the external manipulation section 101 includes a release wire actuation section that has a body 136. The body 136 is mounted onto the thick walled plastic tube 141. The thin walled tube 115 passes through the body 136. The distal wire release mechanism 125 and the proximal wire release mechanism 124 are mounted for slidable movement onto the body 136.
The positioning of the proximal and distal wire release mechanisms 124 and 125 is such that the proximal wire release mechanism 124 must be moved before the distal wire release mechanism 125 can be moved. Therefore, the distal end 142 of the prosthesis 120 cannot be released until the self-expanding zigzag stent 121 has been released, and the barbs 151 have been anchored to the lumen. Clamping screws 137 prevent inadvertent early release of the prosthesis 120. A haemostatic seal (not shown) is included so that the release wires can extend out through the body 136 without unnecessary blood loss during the medical procedure.
A distal portion of the external manipulation section 101 includes a pin vise 139. The pin vise 139 is mounted onto the distal end of the body 136. The pin vise 139 has a screw cap 146. When screwed in, vise jaws (not shown) of the pin vise 139 clamp against or engage the thin walled metal tube 115. When the vise jaws are engaged, the thin walled tube 115 can only move with the body 136, and hence the thin walled tube 115 can only move with the thick walled tube 141. With the screw cap 146 tightened, the entire assembly can be moved together as one piece.
A second introducer may be used to introduce the tubular prosthesis 150. This second introducer may be based on the same principles as the introducer 100 described above, but less complex. For example, the second introducer may include a complex sheath for containing the tubular prosthesis 150 in a compressed state, so that it can be introduced into a targeted anatomy and then released to either self-expand or be actively expanded with a balloon.
The second introducer may also be adapted so that it can introduce the tubular prosthesis 150 by passing it through one ostium in the bifurcated prosthesis 120 and partially out of another ostium until the terminus of the tubular prosthesis 150 that is closest to the external end of the second introducer is properly positioned. At that point, the tubular prosthesis 150 can be released from the second introducer.
Deployment
Prosthetic modules are preferably deployed seriatim. The intermodular connection between the tubular prosthesis 150 and the bifurcated prosthesis 120 is formed in situ. First the bifurcated prosthesis 120 is deployed, and then the tubular prosthesis 150 is deployed. For example, a bifurcated aortic prosthesis 120, as described in WO98/53761, incorporated above by reference in its entirety, can be deployed into the abdominal aorta. The bifurcated prosthesis 120 has a generally inverted Y-shaped configuration having a body portion 123, a shorter leg 160 and a longer leg 132. The body of the prosthesis is constructed from a tubular woven polyester. At the proximal end of the prosthesis 120 is a self-expanding stent 121 which extends beyond the end of the prosthesis and has distally extending barbs 151. The shorter leg 160 and the longer leg 132 have internal projections extending from their distal termini.
This bifurcated prosthesis 120 can be deployed in any method known in the art, preferably the method described in WO98/53761 in which the device is inserted by an introducer via a surgical cut-down into a femoral artery, and then advanced into the desired position over a stiff wire guide using endoluminal interventional techniques. For example, a guide wire (not shown) is first introduced into a femoral artery of the patient and advanced until its tip is beyond the desired deployment region of the prosthesis 120. At this stage, the introducer assembly 100 is fully assembled, and ready for introduction into the patient. The prosthesis 120 is retained at one end by the cylindrical sleeve 110 and the other by the distal attachment sections 140, and compressed by the sheath 130. If an aortic aneurism is to be repaired, the introducer assembly 100 can be inserted through a femoral artery over the guide wire, and positioned by radiographic techniques, which are not discussed here.
Once the introducer assembly 100 is in the desired deployment position, the sheath 130 is withdrawn to just proximal of the distal attachment section 140. This action releases the middle portion of the prosthesis 120 so that it can expand radially. Consequently, the prosthesis 120 can still be rotated or lengthened or shortened for accurate positioning. The proximal self-expanding stent 121, however, is still retained within the cylindrical sleeve 110. Also, the distal end 142 of the prosthesis 120 is still retained within the external sheath 130.
Next, the pin vise 139 is released to allow small movements of the thin walled tube 115 with respect to the thick walled tube 141. These movements allow the prosthesis 120 to be lengthened or shortened or rotated or compressed for accurate placement in the desired location within the lumen. X-ray opaque markers (not shown) may be placed along the prosthesis 120 to assist with placement of the prosthesis.
When the proximal end of the prosthesis 120 is in place, the proximal trigger wire is withdrawn by distal movement of the proximal wire release mechanism 124. The proximal wire release mechanism 124 and the proximal trigger wire can be completely removed by passing the proximal wire release mechanism 124 over the pin vise 139, the screw cap 146, and the connection means 116.
Next, the screw cap 146 of the pin vise 139 is then loosened. After this loosening, the thin walled tube 115 can be pushed in a proximal direction to move the cylindrical sleeve 110 in a proximal direction. When the cylindrical sleeve 110 no longer surrounds the self-expanding stent 121, the self-expanding stent 121 expands. When the self-expanding stent 121 expands, the barbs 151 grip the walls of the lumen to hold the proximal end of the prosthesis 120 in place. From this stage on, the proximal end of the prosthesis 120 cannot be moved again.
Once the proximal end of the prosthesis 120 is anchored, the external sheath 130 is withdrawn distally of the distal attachment section 140. This withdrawal allows the contralateral limb 160 and the longer leg 132 of the prosthesis 120 to expand. At this point, the distal end 142 of the prosthesis 120 may still be moved. Such positioning of the prosthesis 120 may ensure that the shorter leg 160 extends in the direction of a contralateral artery.
After the shorter leg 160 extends in the direction of the contra-iliac artery, the tubular prosthesis 150 is deployed. The tubular prosthesis 150 is deployed such that it forms a connection with the shorter leg 160 and extends from the shorter leg 160 into the contralateral artery.
There are many ways of practicing the invention. For instance, rather than having a continuous chain of running sutures on an outside periphery of the graft, it is possible to strengthen the attachment of the stent by more than one running suture, such as a running suture that links 4 or 5 stitches or apices of a stent to the graft. Other equivalents may include shorter links that join both an anchoring stent and a second stent to the graft, the shorter links comprising as few as two or three apices.
Some anchoring stents are referred to as “top” stents, but an anchoring or top or “bare” stent need not be vertically on top of the graft or another stent. Depending on the application, an anchoring stent may be vertically higher or lower than a neighboring stent, or an anchoring stent may be placed horizontally side by side another stent in a stent-graft or other endoluminal prosthetic device. The embodiments depicted herein include anchoring stents, but embodiments of the invention in which two or more stents are joined in a graft with a running stitch are not limited to anchoring stents. Embodiments may include other stent combinations, such as two internal stents, two external stents, or an internal and an external stent. All such devices and methods may be equivalent to the inventions described above and claimed in the claims attached hereto.
Any other undisclosed or incidental details of the construction or composition of the various elements of the disclosed embodiment of the present invention are not believed to be critical to the achievement of the advantages of the present invention, so long as the elements possess the attributes needed for them to perform as disclosed. The selection of these and other details of construction are believed to be well within the ability of even one of rudimentary skills in this area, in view of the present disclosure.
Illustrative embodiments of the present invention have been described in considerable detail for the purpose of disclosing a practical, operative structure whereby the invention may be practiced advantageously. The designs described herein are intended to be exemplary only. The novel characteristics of the invention may be incorporated in other structural forms without departing from the spirit and scope of the invention. The invention encompasses embodiments both comprising and consisting of the elements described herein with reference to the illustrative embodiments. Unless otherwise indicates, all ordinary words and terms used herein shall take their customary meaning as defined in the New Shorter Oxford English Dictionary, 1993 edition. All technical terms not defined herein shall take on their customary meaning as established by the appropriate technical discipline utilized by those normally skilled in that particular art area. All medical terms not otherwise defined shall take their meaning as defined by Stedman's Medical Dictionary, 27th edition.
This application claims the benefit of the filing date under 35 U.S.C. §119(e) of Provisional U.S. patent application Ser. No. 60/537,980, filed on Jan. 20, 2004, which is hereby incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
4306562 | Osborne | Dec 1981 | A |
4405314 | Cope | Sep 1983 | A |
4430081 | Timmermans | Feb 1984 | A |
4445896 | Gianturco | May 1984 | A |
4494531 | Gianturco | Jan 1985 | A |
4548206 | Osborne | Oct 1985 | A |
4551137 | Osborne | Nov 1985 | A |
4580568 | Gianturco | Apr 1986 | A |
4800882 | Gianturco | Jan 1989 | A |
4907336 | Gianturco | Mar 1990 | A |
5037377 | Alonso | Aug 1991 | A |
5041126 | Gianturco | Aug 1991 | A |
5282824 | Gianturco | Feb 1994 | A |
5314444 | Gianturco | May 1994 | A |
5314472 | Fontaine | May 1994 | A |
5342371 | Welter et al. | Aug 1994 | A |
5443498 | Fontaine | Aug 1995 | A |
5456713 | Chuter | Oct 1995 | A |
5507771 | Gianturco | Apr 1996 | A |
5527354 | Fontaine et al. | Jun 1996 | A |
5562697 | Christiansen | Oct 1996 | A |
5562724 | Vorwerk et al. | Oct 1996 | A |
5562726 | Chuter | Oct 1996 | A |
5562728 | Lazarus et al. | Oct 1996 | A |
5632771 | Boatman et al. | May 1997 | A |
5643339 | Kavteladze et al. | Jul 1997 | A |
5683451 | Lenker et al. | Nov 1997 | A |
5720776 | Chuter et al. | Feb 1998 | A |
5733325 | Robinson et al. | Mar 1998 | A |
5755777 | Chuter | May 1998 | A |
5824037 | Fogarty et al. | Oct 1998 | A |
5824044 | Quiachon et al. | Oct 1998 | A |
5897589 | Cottenceau et al. | Apr 1999 | A |
5935161 | Robinson et al. | Aug 1999 | A |
6004347 | McNamara et al. | Dec 1999 | A |
6015431 | Thornton et al. | Jan 2000 | A |
6024763 | Lenker et al. | Feb 2000 | A |
6077296 | Shokoohi et al. | Jun 2000 | A |
6077297 | Robinson et al. | Jun 2000 | A |
6176875 | Lenker et al. | Jan 2001 | B1 |
6193745 | Fogarty et al. | Feb 2001 | B1 |
6200336 | Pavcnik et al. | Mar 2001 | B1 |
6221102 | Baker et al. | Apr 2001 | B1 |
6231598 | Berry et al. | May 2001 | B1 |
6287330 | Johansson et al. | Sep 2001 | B1 |
6312458 | Golds | Nov 2001 | B1 |
6325819 | Pavcnik et al. | Dec 2001 | B1 |
6524336 | Papazolgou et al. | Feb 2003 | B1 |
6660033 | Marcade et al. | Dec 2003 | B1 |
6899728 | Phillips et al. | May 2005 | B1 |
6951572 | Douglas | Oct 2005 | B1 |
7147660 | Chobotov et al. | Dec 2006 | B2 |
7175652 | Cook et al. | Feb 2007 | B2 |
7238198 | Hartley et al. | Jul 2007 | B2 |
20010041928 | Pavcnik et al. | Nov 2001 | A1 |
20030088305 | Van Schie et al. | May 2003 | A1 |
20030176911 | Iancea et al. | Sep 2003 | A1 |
20030176912 | Chuter et al. | Sep 2003 | A1 |
20040049262 | Obermiller et al. | Mar 2004 | A1 |
20050159803 | Lad et al. | Jul 2005 | A1 |
20050159804 | Lad et al. | Jul 2005 | A1 |
20090299462 | Fawzi et al. | Dec 2009 | A1 |
Number | Date | Country |
---|---|---|
0 508 473 | Oct 1992 | EP |
1 029 517 | Aug 2000 | EP |
1 706 069 | Oct 2006 | EP |
1 706 070 | Feb 2011 | EP |
4887159 | Jul 2007 | JP |
4970053 | Jul 2007 | JP |
2007518532 | Jul 2007 | JP |
2007518538 | Jul 2007 | JP |
2011-218230 | Nov 2011 | JP |
WO 9639999 | Dec 1996 | WO |
WO 0061034 | Oct 2000 | WO |
WO 03075799 | Sep 2003 | WO |
WO 2004002365 | Jan 2004 | WO |
WO 2005070337 | Aug 2005 | WO |
WO 2005070337 | Aug 2005 | WO |
WO 2005070338 | Aug 2005 | WO |
Number | Date | Country | |
---|---|---|---|
20050159803 A1 | Jul 2005 | US |
Number | Date | Country | |
---|---|---|---|
60537980 | Jan 2004 | US |